X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
transarterial chemoembolization (1376) 1376
index medicus (1141) 1141
humans (1136) 1136
hepatocellular carcinoma (963) 963
male (705) 705
liver neoplasms - therapy (681) 681
female (671) 671
middle aged (618) 618
oncology (599) 599
carcinoma, hepatocellular - therapy (575) 575
liver cancer (549) 549
treatment outcome (542) 542
aged (537) 537
cancer (508) 508
hepatoma (495) 495
transcatheter arterial chemoembolization (441) 441
survival (435) 435
chemotherapy (420) 420
liver neoplasms - pathology (419) 419
gastroenterology & hepatology (414) 414
care and treatment (390) 390
adult (385) 385
carcinoma, hepatocellular - pathology (365) 365
radiology, nuclear medicine & medical imaging (360) 360
liver (359) 359
chemoembolization, therapeutic - methods (341) 341
liver neoplasms - mortality (317) 317
radiofrequency ablation (316) 316
retrospective studies (316) 316
surgery (305) 305
embolization (285) 285
carcinoma, hepatocellular - mortality (284) 284
medicine & public health (283) 283
prognosis (276) 276
sorafenib (255) 255
chemoembolization, therapeutic (248) 248
tumors (248) 248
therapy (244) 244
aged, 80 and over (240) 240
management (214) 214
liver neoplasms - drug therapy (210) 210
chemoembolization (203) 203
hepatocellular-carcinoma (203) 203
survival rate (203) 203
analysis (201) 201
neoplasm staging (190) 190
patients (190) 190
liver neoplasms - surgery (185) 185
antineoplastic agents - administration & dosage (172) 172
microspheres (172) 172
risk factors (169) 169
combined modality therapy (168) 168
carcinoma, hepatocellular - drug therapy (166) 166
chemoembolization, therapeutic - adverse effects (166) 166
carcinoma, hepatocellular - surgery (163) 163
liver transplantation (161) 161
radiotherapy (161) 161
metastasis (159) 159
hepatectomy (155) 155
resection (147) 147
drug-eluting beads (140) 140
survival analysis (140) 140
randomized controlled trial (138) 138
health aspects (137) 137
imaging / radiology (137) 137
medical prognosis (136) 136
efficacy (133) 133
ablation (132) 132
liver-transplantation (131) 131
randomized controlled-trial (131) 131
cancer therapies (129) 129
antineoplastic agents - therapeutic use (127) 127
doxorubicin (127) 127
tace (127) 127
time factors (126) 126
liver neoplasms - diagnostic imaging (122) 122
recurrence (122) 122
unresectable hepatocellular-carcinoma (119) 119
tomography, x-ray computed (118) 118
hepatic resection (117) 117
kaplan-meier estimate (117) 117
radioembolization (116) 116
usage (115) 115
digestive system diseases (114) 114
radiology (114) 114
liver neoplasms - secondary (113) 113
disease-free survival (112) 112
diagnosis (111) 111
liver metastases (111) 111
percutaneous ethanol injection (111) 111
cirrhosis (110) 110
ultrasound (109) 109
drug therapy (108) 108
multivariate analysis (107) 107
research (107) 107
animals (106) 106
doxorubicin - administration & dosage (106) 106
transplantation (105) 105
hepatology (102) 102
patient outcomes (102) 102
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1754) 1754
German (34) 34
Korean (30) 30
French (8) 8
Icelandic (2) 2
Japanese (2) 2
Polish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, ISSN 1055-3207, 10/2019, Volume 28, Issue 4, pp. 717 - 717
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 12/2018, Volume 292, pp. 18 - 28
The prevailing paradigm of locoregional chemotherapy has been centred around delivering chemotherapy as close to the tumour as possible and in some cases... 
ISOLATED HEPATIC PERFUSION | DRUG-ELUTING BEADS | HEPATOCELLULAR-CARCINOMA | CHEMORADIATION THERAPY | TRANSARTERIAL CHEMOEMBOLIZATION | PHARMACOLOGY & PHARMACY | EXTRACORPOREAL LIMB PERFUSION | PHASE-I | CHEMISTRY, MULTIDISCIPLINARY | ISOLATED LUNG PERFUSION | INTRAARTERIAL CHEMOTHERAPY | PULMONARY METASTASES | Chemotherapy | Analysis | Liver | Cancer
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 04/2012, Volume 24, Issue 4, pp. 437 - 443
BACKGROUNDUnresectable cholangiocarcinoma (CCC) has a poor prognosis. Patients with intrahepatic CCC have a very limited benefit from systemic chemotherapy... 
Irinotecan | Biliary tract cancer | Drug eluting beads | Transarterial chemoembolization | Cholangiocarcinoma | biliary tract cancer | BILIARY-TRACT CANCER | INTRAHEPATIC CHOLANGIOCARCINOMA | irinotecan | INITIAL-EXPERIENCE | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | drug eluting beads | INTRAARTERIAL CHEMOTHERAPY | LIVER METASTASES | PHASE-II TRIAL | HEPATOCELLULAR-CARCINOMA | IN-VITRO | COLORECTAL-CANCER | transarterial chemoembolization | GASTROENTEROLOGY & HEPATOLOGY | cholangiocarcinoma | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Male | Liver Neoplasms - therapy | Gelatin Sponge, Absorbable - administration & dosage | Chemoembolization, Therapeutic - methods | Microspheres | Antineoplastic Agents, Phytogenic - administration & dosage | Organoplatinum Compounds - administration & dosage | Aged, 80 and over | Adult | Bile Ducts, Intrahepatic | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Antineoplastic Agents, Phytogenic - adverse effects | Camptothecin - analogs & derivatives | Mitomycin - adverse effects | Camptothecin - adverse effects | Cholangiocarcinoma - therapy | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Antibiotics, Antineoplastic - administration & dosage | Gelatin Sponge, Absorbable - adverse effects | Bile Duct Neoplasms - therapy | Epidemiologic Methods | Chemoembolization, Therapeutic - adverse effects | Aged | Mitomycin - administration & dosage | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
Journal of Computer Assisted Tomography, ISSN 0363-8715, 11/2011, Volume 35, Issue 6, pp. 690 - 696
Journal Article
European Journal of Radiology, ISSN 0720-048X, 05/2018, Volume 102, pp. 138 - 145
To determine overall (OS) and progression-free survival (PFS) for cTACE alone and in combination with percutaneous thermal ablation in patients with... 
Microwave ablation (MWA) | Colorectal cancer liver metastases (CRLM) | Conventional transarterial chemoembolization (cTACE) | Percutaneous thermal ablation | Colorectal cancer (CRC) | Laser-induced thermotherapy (LITT) | RESECTION | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | DEGRADABLE STARCH MICROSPHERES | HEPATIC METASTASES | THERAPY | CISPLATIN | SYSTEMIC CHEMOTHERAPY | RADIOEMBOLIZATION | LASER-INDUCED THERMOTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prognosis | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Microwaves - therapeutic use | Cisplatin - administration & dosage | Chemoembolization, Therapeutic - methods | Ethiodized Oil - administration & dosage | Young Adult | Neoadjuvant Therapy - mortality | Ablation Techniques - mortality | Aged, 80 and over | Adult | Female | Laser Therapy - methods | Retrospective Studies | Hyperthermia, Induced - methods | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Colonic Neoplasms - mortality | Deoxycytidine - administration & dosage | Survival Rate | Treatment Outcome | Chemoembolization, Therapeutic - mortality | Laser Therapy - mortality | Rectal Neoplasms - mortality | Disease-Free Survival | Ablation Techniques - methods | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Aged | Hyperthermia, Induced - mortality | Mitomycin - administration & dosage | Deoxycytidine - analogs & derivatives | Palliative Care - methods | Ablation (Surgery) | Analysis | Oncology, Experimental | Patient outcomes | Colorectal cancer | Adjuvant treatment | Metastasis | Research | Cancer
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 3/2017, Volume 143, Issue 3, pp. 481 - 489
Journal Article